TRENTON, N.J.--(BUSINESS WIRE)--New Jersey’s biotechnology industry continued to both grow and mature in 2007, according to the latest BioNJ industry survey. The industry expanded as measured by several important factors, with the number of public and private companies located in the State increasing beyond 2005 levels, while public companies experienced growth in the number of employees, revenues, research and development expenditures and market cap, according to New Jersey Life Sciences…Where Science is Life, a survey released today by BioNJ with assistance from Ernst & Young.
